FDA Puts Clinical Trial for CRISPR Therapy on Hold – Labiotech.eu (blog)
MIT Technology Review |
FDA Puts Clinical Trial for CRISPR Therapy on Hold
Labiotech.eu (blog) The FDA has put a hold on CRISPR Therapeutics' planned Phase I/II trial testing a CRISPR gene-editing therapy in patients with sickle cell disease. CRISPR Therapeutics, based in Basel, Switzerland, and its partner Vertex Pharmaceuticals will have to … FDA halts one of the first human CRISPR studies before it begins The FDA Puts the Brakes on a Major CRISPR Trial in Humans Is Crispr Therapeutics Stock a Bad News Buy? |
